Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells

T lymphocytes represent a promising target for genome editing. They are primarily modified to recognize and kill tumor cells or to withstand HIV infection. In most studies, T cell genome editing is performed using the CRISPR/Cas technology. Although this technology is easily programmable and widely...

Full description

Bibliographic Details
Main Authors: Natalia Kruglova, Mikhail Shepelev
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/12/1/119
_version_ 1797340099243933696
author Natalia Kruglova
Mikhail Shepelev
author_facet Natalia Kruglova
Mikhail Shepelev
author_sort Natalia Kruglova
collection DOAJ
description T lymphocytes represent a promising target for genome editing. They are primarily modified to recognize and kill tumor cells or to withstand HIV infection. In most studies, T cell genome editing is performed using the CRISPR/Cas technology. Although this technology is easily programmable and widely accessible, its efficiency of T cell genome editing was initially low. Several crucial improvements were made in the components of the CRISPR/Cas technology and their delivery methods, as well as in the culturing conditions of T cells, before a reasonable editing level suitable for clinical applications was achieved. In this review, we summarize and describe the aforementioned parameters that affect human T cell editing efficiency using the CRISPR/Cas technology, with a special focus on gene knock-in.
first_indexed 2024-03-08T09:58:05Z
format Article
id doaj.art-b318ab43fa004fa3addc2cc119155c18
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-08T09:58:05Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-b318ab43fa004fa3addc2cc119155c182024-01-29T13:47:18ZengMDPI AGBiomedicines2227-90592024-01-0112111910.3390/biomedicines12010119Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T CellsNatalia Kruglova0Mikhail Shepelev1Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology RAS, 119334 Moscow, RussiaCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology RAS, 119334 Moscow, RussiaT lymphocytes represent a promising target for genome editing. They are primarily modified to recognize and kill tumor cells or to withstand HIV infection. In most studies, T cell genome editing is performed using the CRISPR/Cas technology. Although this technology is easily programmable and widely accessible, its efficiency of T cell genome editing was initially low. Several crucial improvements were made in the components of the CRISPR/Cas technology and their delivery methods, as well as in the culturing conditions of T cells, before a reasonable editing level suitable for clinical applications was achieved. In this review, we summarize and describe the aforementioned parameters that affect human T cell editing efficiency using the CRISPR/Cas technology, with a special focus on gene knock-in.https://www.mdpi.com/2227-9059/12/1/119CRISPR/Casgenome editingprimary T cellsknock-inHDRCAR T
spellingShingle Natalia Kruglova
Mikhail Shepelev
Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells
Biomedicines
CRISPR/Cas
genome editing
primary T cells
knock-in
HDR
CAR T
title Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells
title_full Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells
title_fullStr Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells
title_full_unstemmed Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells
title_short Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells
title_sort increasing gene editing efficiency via crispr cas9 or cas12a mediated knock in in primary human t cells
topic CRISPR/Cas
genome editing
primary T cells
knock-in
HDR
CAR T
url https://www.mdpi.com/2227-9059/12/1/119
work_keys_str_mv AT nataliakruglova increasinggeneeditingefficiencyviacrisprcas9orcas12amediatedknockininprimaryhumantcells
AT mikhailshepelev increasinggeneeditingefficiencyviacrisprcas9orcas12amediatedknockininprimaryhumantcells